Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Social Media Screening for ADR-monitoring โ€“ Like it or not!

Posted on December 16th, 2015 by in Pharmacovigilance

Social Media and Pharmacovigilance

Limitations of clinical trials and traditional post-marketing sources of safety information.ย 

Due to limitations of pre-marketing clinical trials, there isnโ€™t much information available once a medicinal product is authorized for marketing. (more…)

Ensuring the Safety of New Antipsychotics

Posted on October 30th, 2015 by in Chemistry

Antipsychotics have complex pharmacological profiles and adverse events are common with long-term use. New or optimized drugs with better safety profiles are desirable. The best way to get information on a new compound that has potential as an antipsychotic is to use in silico profiling to compare it to existing drugs, as described in this new paper.

Read all about drug safety of new antipsychotics.

  1. 1
  2. 2
  3. 3
  4. 4